TLC-3595

N/A

Report date: 2025/01/08 15:16:21
NME

Base Information

Drug NameTLC-3595
Drug Alias NameS-723595TLC-3595
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetyl-CoA carboxylase 2 inhibitors
TargetsAcetyl-CoA carboxylase 2
Therapy Area/IndicationsInsulin ResistanceDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOrsoBio IncShionogi & Co Ltd
Inactive CompaniesN/A
Active IndicationsInsulin ResistanceDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A